title: [Therapeutic advances in neurology].
abstract: The neurology field has been greatly improved in 2008. The therapeutic window of intravenous thrombolysis for acute ischemic stoke is extended to 4 h 30. New studies show that the clinical progression of Parkinson's disease might be slowed by some medication. Deep brain stimulation may be beneficial early in the course of the disease. Tysabri and Fingolimod in multiple sclerosis are discussed. The pharmacopoeia for epilepsy is in constant development with new products recently released in Switzerland. CGRP receptor antagonists are about to be launched as a promising acute migraine treatment. The pharmacological approach in amyotrophic lateral sclerosis patients might be improved according to research results.
authors.affiliation: Service de neurologie, CHUV, Lausanne. julien.morier@chuv.ch
authors.forename: J
authors.initials: J
authors.lastname: Morier
authors.forename: R
authors.initials: R
authors.lastname: Du Pasquier
authors.forename: T
authors.initials: T
authors.lastname: Kuntzer
authors.forename: P
authors.initials: P
authors.lastname: Michel
authors.forename: B
authors.initials: B
authors.lastname: Nater
authors.forename: J
authors.initials: J
authors.lastname: Niederhauser
authors.forename: A O
authors.initials: AO
authors.lastname: Rossetti
authors.forename: M
authors.initials: M
authors.lastname: Schluep
authors.forename: F
authors.initials: F
authors.lastname: Vingerhoets
mesh_terms: D006801:Humans; D009422:Nervous System Diseases / Q000628:therapy*; D009462:Neurology / Q000639:trends*